September 5th 2019EP. 1: The Nature and Cost of Multiple Sclerosis
September 5th 2019EP. 2: Is Multiple Sclerosis Truly an Autoimmune Disease?
September 5th 2019EP. 3: Multiple Sclerosis: Making a Diagnosis
September 5th 2019EP. 4: Tests Involved in a Diagnostic Workup of Multiple Sclerosis
September 5th 2019EP. 5: Multiple Sclerosis: Benefit of Early Diagnosis
September 5th 2019EP. 6: Overview of Multiple Sclerosis Subtypes
September 5th 2019EP. 7: Understanding the Transition From RRMS to SPMS
September 5th 2019EP. 8: Discrepancy in Defining Secondary-Progressive Multiple Sclerosis
September 5th 2019EP. 9: Role of a Specialist Versus PCP in Multiple Sclerosis
September 5th 2019EP. 10: How Are Outcomes of Progressive MS Measured?
September 5th 2019EP. 11: Approaching the Management of Multiple Sclerosis
September 5th 2019EP. 12: Ocrelizumab Use in Treating Multiple Sclerosis
September 5th 2019EP. 13: Siponimod's Role in Managing Multiple Sclerosis
September 5th 2019EP. 14: Optimizing the Use of Disease Modifying Therapy in Multiple Sclerosis
September 5th 2019EP. 15: Cost of Disease-Modifying Therapy in Multiple Sclerosis
September 5th 2019EP. 16: Multiple Sclerosis: Balancing Cost and Access to Therapy
September 5th 2019EP. 17: Moving the MS Treatment Paradigm Forward
